Sonnet BioTherapeutics

+$0.0003 (+0.05%) Today
-$0.0154 (-2.35%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SONN and other ETFs, options, and stocks.

About SONN

Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues.

CEO
Pankaj Mohan
Employees
9
Headquarters
Princeton, New Jersey
Founded
2011

SONN Key Statistics

Market Cap
38.11M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
5.55M
High Today
$0.6679
Low Today
$0.6509
Open Price
$0.663
Volume
2.45M
52 Week High
$3.42
52 Week Low
$0.5508

SONN Earnings

-$4.73
-$3.15
-$1.58
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Dec 13, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure